Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 4 days ago 34 Далее Скачать
FLAIR trial: improved outcomes with MRD-guided ibrutinib plus venetoclax in CLL compared to FCR VJHemOnc – Video Journal of Hematology & HemOnc 3:00 1 year ago 365 Далее Скачать
Achieving undetectable MRD with ibrutinib plus venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 219 Далее Скачать
HOVON 141/VISION trial update: MRD-guided venetoclax + ibrutinib treatment for R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:21 1 year ago 185 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
Exploratory analysis of the CLARITY study: ibrutinib plus venetoclax in patients with R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 173 Далее Скачать
ERADIC trial: preliminary results of MRD-guided ibrutinib plus venetoclax vs FCR VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 75 Далее Скачать
Venetoclax and ibrutinib therapy shows favourable results in the treatment of R/R CLL ecancer 7:15 1 year ago 34 Далее Скачать
MRD-driven addition of ibrutinib to venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:36 3 years ago 115 Далее Скачать
ASH CLL highlights: ibrutinib-venetoclax combination & undetectable MRD in IGHV-mutated patients VJHemOnc – Video Journal of Hematology & HemOnc 1:47 2 years ago 536 Далее Скачать
The role of MRD in clinical decision-making in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:35 2 years ago 100 Далее Скачать
The impact of MRD & genetics on outcomes to time-limited combinations in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:55 2 years ago 107 Далее Скачать
Interim analysis of the FLAIR study: efficacy of ibrutinib plus venetoclax in IgHV unmutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 1 year ago 328 Далее Скачать
Ibrutinib plus venetoclax for first-line treatment of CLL: 4-year follow-up data VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 485 Далее Скачать
HOVON 141/VISION: MRD guided time-limited treatment in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:10 2 years ago 126 Далее Скачать
GLOW: Assessing ibrutinib plus venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 364 Далее Скачать
Updates in CLL: key clinical trials in the frontline and R/R setting, pre-clinical data and MRD VJHemOnc – Video Journal of Hematology & HemOnc 17:23 2 years ago 1 124 Далее Скачать
Minimal residual disease (MRD) in CLL: Is it clinically relevant? HMP Education 21:09 6 years ago 1 744 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
